Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

Authors

Zhuoqun Sun
Zhuhang Huang (ORCID: https://orcid.org/0000-0001-8766-3576)
Hengming Zhang (ORCID: https://orcid.org/0000-0003-4225-1265)
Lianhao Wang
Yajun Shu
Shaomin Chen (ORCID: https://orcid.org/0000-0001-6417-7719)
Zhifang Ying
Fan Gao (ORCID: https://orcid.org/0000-0002-2828-256X)
Xing Meng (ORCID: https://orcid.org/0000-0002-5309-7681)
Qun Shu
Jikai Zhang

Institutions

Sinovac Biotech (CN)
Guangdong Institute of Biological Products and Drugs (CN)
National Institutes for Food and Drug Control (CN)

Publication Details

Journal: Human Vaccines & Immunotherapeutics
Published: 2024-09-23
DOI: https://doi.org/10.1080/21645515.2024.2402644
Citations: 1
Primary Topic: SARS-CoV-2 and COVID-19 Research
Type: article
Field-Weighted Citation Impact: 0.39

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

Zhuoqun Sun, Zhuhang Huang, Hengming Zhang, Lianhao Wang et al.

Sep 23, 2024

1 citations

Human Vaccines & Immunotherapeutics

SARS-CoV-2 and COVID-19 Research

0.39

article

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

Zhuoqun Sun, Zhuhang Huang, Hengming Zhang, Lianhao Wang, Yajun Shu, Shaomin Chen, Zhifang Ying, Fan Gao, Xing Meng, Qun Shu, Jikai Zhang

September 23, 2024article en

1 citations

Abstract

No abstract available for this paper.

Human Vaccines & ImmunotherapeuticsVol. 20(1)

Sinovac Biotech (CN), Guangdong Institute of Biological Products and Drugs (CN), National Institutes for Food and Drug Control (CN)

Good health and well-being

Openalex Percentile: Top 37%

SARS-CoV-2 and COVID-19 Research

0.39

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.